SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:umu-57638"
 

Sökning: onr:"swepub:oai:DiVA.org:umu-57638" > Evidence for FHL1 a...

Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy

Friedrich, Felix W. (författare)
Wilding, Brendan R. (författare)
Reischmann, Silke (författare)
visa fler...
Crocini, Claudia (författare)
Lang, Patrick (författare)
Charron, Philippe (författare)
Mueller, Oliver J. (författare)
McGrath, Meagan J. (författare)
Vollert, Ingra (författare)
Hansen, Arne (författare)
Linke, Wolfgang A. (författare)
Hengstenberg, Christian (författare)
Bonne, Gisele (författare)
Mörner, Stellan (författare)
Umeå universitet,Kardiologi
Wichter, Thomas (författare)
Madeira, Hugo (författare)
Arbustini, Eloisa (författare)
Eschenhagen, Thomas (författare)
Mitchell, Christina A. (författare)
Isnard, Richard (författare)
Carrier, Lucie (författare)
visa färre...
 (creator_code:org_t)
Oxford University Press, 2012
2012
Engelska.
Ingår i: Human Molecular Genetics. - : Oxford University Press. - 0964-6906 .- 1460-2083. ; 21:14, s. 3237-3254
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Hypertrophic cardiomyopathy (HCM) is characterized by asymmetric left ventricular hypertrophy, diastolic dysfunction and myocardial disarray. HCM is caused by mutations in sarcomeric genes, but in 40 of patients, the mutation is not yet identified. We hypothesized that FHL1, encoding four-and-a-half-LIM domains 1, could be another disease gene since it has been shown to cause distinct myopathies, sometimes associated with cardiomyopathy. We evaluated 121 HCM patients, devoid of a mutation in known disease genes. We identified three novel variants in FHL1 (c.134delA/K45Sfs, c.459CA/C153X and c.827GC/C276S). Whereas the c.459CA variant was associated with muscle weakness in some patients, the c.134delA and c.827GC variants were associated with isolated HCM. Gene transfer of the latter variants in C2C12 myoblasts and cardiac myocytes revealed reduced levels of FHL1 mutant proteins, which could be rescued by proteasome inhibition. Contractility measurements after adeno-associated virus transduction in rat-engineered heart tissue (EHT) showed: (i) higher and lower forces of contraction with K45Sfs and C276S, respectively, and (ii) prolonged contraction and relaxation with both mutants. All mutants except one activated the fetal hypertrophic gene program in EHT. In conclusion, this study provides evidence for FHL1 to be a novel gene for isolated HCM. These data, together with previous findings of proteasome impairment in HCM, suggest that FHL1 mutant proteins may act as poison peptides, leading to hypertrophy, diastolic dysfunction and/or altered contractility, all features of HCM.

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy